Use of β-Blockers in Patients with COPD

Andrus, Miranda R.; Holloway, Katherine P; Clark, Deidre B.

doi:10.1345/aph.1d113

Cited by 35 publications

(14 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several meta-analyses concluded that cardioselective β-blockers do not produce clinically significant adverse respiratory effects in patients with chronic obstructive pulmonary disease, suggesting that β-blockers should not be withheld from these patients. 196,197 …”

Section: β-Blockersmentioning

confidence: 99%

Treatment of Hypertension in Patients With Coronary Artery Disease

Rosendorff¹,

Lackland²,

Allison³

et al. 2015

Hypertension

111

View full text Add to dashboard Cite

Section: β-Blockersmentioning

confidence: 99%

Treatment of Hypertension in Patients With Coronary Artery Disease

Rosendorff¹,

Lackland²,

Allison³

et al. 2015

Hypertension

111

View full text Add to dashboard Cite

“…Two recent meta-analyses concluded that cardioselective ␤-blockers do not produce clinically significant adverse respiratory effects in patients with mild to moderate reactive airway disease, 110,111 which suggests that ␤-blockers should not be withheld from these patients.…”

Section: ␤-Blockersmentioning

confidence: 99%

Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease

Rosendorff¹,

Black²,

Cannon³

et al. 2007

Circulation

688

235

View full text Add to dashboard Cite

“…Criteria from the adjusted Beers list, McLeod's list, and Lindblad's list of clinically important drug-disease interactions are combined and respective data updated [10][11][12][61][62][63][64][65][66][67][68][69]. Some of the inappropriate drugdisease combinations are defined by all three tools, such as NSAIDs in peptic ulcer disease or tricyclic antidepressant in benign prostate hyperplasia.…”

Section: The New Comprehensive Protocolmentioning

confidence: 99%

Potentially inappropriate medications in the elderly: a comprehensive protocol

Matanović

Vlahović‐Palčevski

2012

Eur J Clin Pharmacol

View full text Add to dashboard Cite

Elderly patients are at increased risk of drug-related morbidity and mortality. Avoiding the use of potentially inappropriate medications (PIMs) is one of the strategies that has been widely adopted to reduce the harmful consequences of drug use. There are several PIM screening tools available. In this review, we provide an overview of existing screening tools to detect PIMs in the elderly, emphasizing the advantages and disadvantages of each. Combining previously published and adopted tools (adjusted Beers list, French consensus panel, McLeod's list, and Lindblad's list of clinically important drug-disease interactions), we develop a new comprehensive tool that also includes the adjusted Hanlon's and Malone's lists of potentially serious drug-drug interactions in the elderly. In addition to listed PIMs and clinically important drug-drug interactions, alternative therapeutic solutions are suggested. The new protocol differentiates: drugs with an unfavorable benefit/risk ratio (to be avoided regardless of the underlying disease/condition), drugs with a questionable efficacy, and drugs to be avoided with certain diseases/conditions, and provides a list of potentially serious drug-drug interactions. A tool consisting of PIMs and potential drug-drug interactions within the same protocol provides more comprehensive quality assessment of drug-prescribing behavior to the elderly, which in turn may lead to better prescribing practices.

show abstract

Use of β-Blockers in Patients with COPD

Abstract: The literature supports the safety and mortality benefits of using beta-blockers in COPD. Patients with mild to moderate COPD should receive cardioselective beta-blocker therapy when a strong indication exists.

Cited by 35 publications

References 27 publications

Treatment of Hypertension in Patients With Coronary Artery Disease

Treatment of Hypertension in Patients With Coronary Artery Disease

Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease

Potentially inappropriate medications in the elderly: a comprehensive protocol

Contact Info

Product

Resources

About